As you have likely heard in the news, the Food and Drug Administration issued an Emergency Use Authorization (EUA) for Pfizer’s COVID-19 vaccine and we expect a second EUA for Moderna’s vaccine to be issued shortly after December 17. The vaccine has been authorized for use in the prevention of 2019 coronavirus disease (COVID-19) for individuals 16 years of age and older.
What You Need to Know
Many details surrounding the distribution of the vaccine remain to be seen, however in an effort to keep you as up-to-date as possible we are providing the current information available below. We will continue to share more details about the COVID-19 vaccine as they become available.
At this time, as per the major carriers (Cigna, UHC, Oxford, Aetna, BCBS) patients will have no out-of-pocket cost for the vaccine or administration cost. The vaccine is initially provided by government. The administration cost is paid for by the carrier’s medical or prescription plan.
The COVID-19 vaccine supply will initially be limited, with the first doses designated for frontline healthcare workers and residents of long-term care facilities. Over the next three to four months we anticipate that vaccine supply will increase significantly and there will be opportunities for additional groups to be vaccinated.
MBL is committed to keeping our clients informed about the vaccine, including its distribution, related costs and legal concerns that may pertain to employees.
Feel free to reach out to us with any immediate questions at email@example.com. Wishing you continued safety and health during this holiday season and new year!